Si-Tu Xue

567 total citations
30 papers, 432 citations indexed

About

Si-Tu Xue is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Si-Tu Xue has authored 30 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Si-Tu Xue's work include Bone Metabolism and Diseases (7 papers), Bone health and treatments (5 papers) and FOXO transcription factor regulation (4 papers). Si-Tu Xue is often cited by papers focused on Bone Metabolism and Diseases (7 papers), Bone health and treatments (5 papers) and FOXO transcription factor regulation (4 papers). Si-Tu Xue collaborates with scholars based in China. Si-Tu Xue's co-authors include Zhuorong Li, Hong Yi, Jian‐Dong Jiang, Zong‐Ying Liu, Xingyue Ji, Jiajia Shen, Huifang Guo, Yuhuan Li, Yang Gao and Rong‐Mei Gao and has published in prestigious journals such as Nature Communications, Cell Metabolism and International Journal of Molecular Sciences.

In The Last Decade

Si-Tu Xue

30 papers receiving 425 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Si-Tu Xue 199 190 78 46 43 30 432
Shankar Jayarama 224 1.1× 137 0.7× 62 0.8× 23 0.5× 40 0.9× 29 441
Zi Hui 262 1.3× 127 0.7× 91 1.2× 25 0.5× 27 0.6× 32 453
José D. Solano 233 1.2× 159 0.8× 59 0.8× 22 0.5× 47 1.1× 22 450
Supriya Bhukya 137 0.7× 171 0.9× 63 0.8× 25 0.5× 50 1.2× 13 354
Changkun Hu 316 1.6× 414 2.2× 82 1.1× 95 2.1× 33 0.8× 26 691
Chih‐Mei Cheng 275 1.4× 234 1.2× 48 0.6× 58 1.3× 36 0.8× 18 572
Joana B. Loureiro 237 1.2× 69 0.4× 155 2.0× 21 0.5× 46 1.1× 20 413
Weijie Gao 247 1.2× 108 0.6× 76 1.0× 15 0.3× 24 0.6× 15 388
Amit Ketkar 432 2.2× 127 0.7× 60 0.8× 28 0.6× 77 1.8× 30 603

Countries citing papers authored by Si-Tu Xue

Since Specialization
Citations

This map shows the geographic impact of Si-Tu Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Si-Tu Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Si-Tu Xue more than expected).

Fields of papers citing papers by Si-Tu Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Si-Tu Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Si-Tu Xue. The network helps show where Si-Tu Xue may publish in the future.

Co-authorship network of co-authors of Si-Tu Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Si-Tu Xue. A scholar is included among the top collaborators of Si-Tu Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Si-Tu Xue. Si-Tu Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yong‐Jian, Si-Tu Xue, Yi Hong, et al.. (2025). A Novel Class of Multi‐substituted Diaryl Scaffold Derivatives Inhibit Glioblastoma Progression by Targeting CD155. Advanced Science. 12(32). e06688–e06688. 1 indexed citations
2.
Jiang, Huimin, Yong‐Jian Wang, Shujuan Wang, et al.. (2025). Cathepsin D promotes acute myeloid leukemia progression through stabilization of the anti-apoptotic proteins. Cell Death and Disease. 16(1). 611–611. 1 indexed citations
3.
Zhao, Chenxi, Tingting Zhang, Si-Tu Xue, et al.. (2024). Adipocyte-derived glutathione promotes obesity-related breast cancer by regulating the SCARB2-ARF1-mTORC1 complex. Cell Metabolism. 37(3). 692–707.e9. 11 indexed citations
4.
Zhao, Luyao, et al.. (2024). Substituted indole derivatives as UNC-51-like kinase 1 inhibitors: Design, synthesis and anti-hepatocellular carcinoma activity. Biomedicine & Pharmacotherapy. 178. 117260–117260. 2 indexed citations
5.
Zhao, Chenxi, et al.. (2024). BMP2–ERK–ATF4 Axis-Based 6-methoxybenzofuran Compound I-9 Acts as Candidate Drug for Bone Formation and Anti-Osteoporosis. International Journal of Molecular Sciences. 25(6). 3350–3350. 3 indexed citations
6.
Xue, Si-Tu, et al.. (2024). Osteoporosis: Emerging targets on the classical signaling pathways of bone formation. European Journal of Pharmacology. 973. 176574–176574. 6 indexed citations
7.
Zhang, Lei, et al.. (2023). Design and synthesis of dabigatran etexilate derivatives with inhibiting thrombin activity for hepatocellular carcinoma treatment. Biomedicine & Pharmacotherapy. 170. 116018–116018. 1 indexed citations
8.
Wang, Feng, Yang Gao, Si-Tu Xue, et al.. (2023). SCARB2 drives hepatocellular carcinoma tumor initiating cells via enhanced MYC transcriptional activity. Nature Communications. 14(1). 5917–5917. 15 indexed citations
9.
Xue, Si-Tu, et al.. (2022). Small molecule targeting FOXM1 DNA binding domain exhibits anti-tumor activity in ovarian cancer. Cell Death Discovery. 8(1). 280–280. 21 indexed citations
10.
Xue, Si-Tu, et al.. (2022). Structure-based virtual screening identified novel FOXM1 inhibitors as the lead compounds for ovarian cancer. Frontiers in Chemistry. 10. 1058256–1058256. 4 indexed citations
11.
Geng, Jing, et al.. (2022). Synthesis and antineoplastic activity of ethylene glycol phenyl aminoethyl ether derivatives as FOXM1 inhibitors. European Journal of Medicinal Chemistry. 244. 114877–114877. 1 indexed citations
12.
13.
Sun, Wenfang, Jie Jin, Si-Tu Xue, et al.. (2020). <p>Synthesis and Bioactivity of <em>N</em>-(4-Chlorophenyl)-4-Methoxy-3-(Methylamino) Benzamide as a Potential Anti-HBV Agent</p>. Drug Design Development and Therapy. Volume 14. 3723–3729. 4 indexed citations
14.
Wang, Linlin, Jiansong Fang, Hailun Jiang, et al.. (2019). 7-Pyrrolidinethoxy-4′-Methoxyisoflavone Prevents Amyloid β–Induced Injury by Regulating Histamine H3 Receptor-Mediated cAMP/CREB and AKT/GSK3β Pathways. Frontiers in Neuroscience. 13. 334–334. 9 indexed citations
15.
Wang, Yali, Si-Tu Xue, Ruolan Li, et al.. (2017). Synthesis and biological evaluation of novel synthetic chalcone derivatives as anti-tumor agents targeting Cat L and Cat K. Bioorganic & Medicinal Chemistry. 26(1). 8–16. 23 indexed citations
16.
Jiang, Zhi‐Hong, Jiajia Shen, Hong Yi, et al.. (2016). Design, synthesis and biological evaluation of novel benzimidazole-2-substituted phenyl or pyridine propyl ketene derivatives as antitumour agents. European Journal of Medicinal Chemistry. 114. 328–336. 44 indexed citations
17.
18.
Xue, Si-Tu, Linlin Ma, Rong‐Mei Gao, Yuhuan Li, & Zhuorong Li. (2014). Synthesis and antiviral activity of some novel indole-2-carboxylate derivatives. Acta Pharmaceutica Sinica B. 4(4). 313–321. 29 indexed citations
19.
Ji, Xingyue, Si-Tu Xue, Jiajia Shen, et al.. (2014). Design, synthesis and antiproliferative activity of a novel class of indole-2-carboxylate derivatives. European Journal of Medicinal Chemistry. 83. 409–418. 15 indexed citations
20.
Zheng, Guanghui, Jiajia Shen, Yi Hong, et al.. (2014). Design, synthesis and in vitro and in vivo antitumour activity of 3-benzylideneindolin-2-one derivatives, a novel class of small-molecule inhibitors of the MDM2–p53 interaction. European Journal of Medicinal Chemistry. 81. 277–288. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shankar Jayarama Breakdown of academic impact, for papers by Zi Hui Breakdown of academic impact, for papers by José D. Solano Breakdown of academic impact, for papers by Supriya Bhukya Breakdown of academic impact, for papers by Changkun Hu Breakdown of academic impact, for papers by Chih‐Mei Cheng Breakdown of academic impact, for papers by Joana B. Loureiro Breakdown of academic impact, for papers by Weijie Gao Breakdown of academic impact, for papers by Amit Ketkar
Rankless by CCL
2026